Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population

被引:50
作者
Tinahones, FJ [1 ]
Gómez-Zumaquero, JM
Garrido-Sánchez, L
García-Fuentes, E
Rojo-Martínez, G
Esteva, I
de Adana, MSR
Cardona, F
Soriguer, F
机构
[1] Carlos Haya Reg Univ Hosp, Serv Endocrinol & Nutr, Malaga, Spain
[2] Carlos Haya Reg Univ Hosp, Lab Invest, Malaga, Spain
关键词
low density lipoprotein; oxidized low density lipoproteins; atherosclerosis;
D O I
10.1194/jlr.M400290-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most studies of antibodies to oxidized LDL have been undertaken in patients with different diseases and cardiovascular risk factors. However, very few studies have researched the distribution and determining factors of antibodies to oxidized LDL in the general population. A total of 1,354 persons ( 817 females and 537 males) aged 5-65 years were included in this study. They were selected randomly from the population census of Malaga, in southern Spain. The females had lower levels of total cholesterol and triglycerides and higher levels of HDL- cholesterol and a very significant increase ( P < 0.0001) in levels of anti- oxidized LDL [ low density lipoprotein modified by malondialdehyde ( MDA- LDL)] antibodies but no difference in levels of immune complexes consisting of LDL and IgG antibodies (anti-LDL immune complex). Younger persons ( 16 - 35 years) had higher levels of anti-oxidized LDL ( MDA-LDL) antibodies than persons older than 35 years ( P = 0.05). Levels of immune complexes were significantly higher ( P = 0.05) in persons aged 5 - 15 years than in persons older than 40 years. A very weak association was found between levels of anti- oxidized LDL ( MDA-LDL) antibodies and anti- LDL immune complexes. The higher prevalence of anti-oxidized LDL ( MDA-LDL) antibodies in females and young persons is in agreement with studies that found an inverse association between atherosclerosis and the level of these antibodies.
引用
收藏
页码:452 / 457
页数:6
相关论文
共 27 条
[1]   Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits [J].
Ameli, S ;
HultgardhNilsson, A ;
Regnstrom, J ;
Calara, F ;
Yano, J ;
Cercek, B ;
Shah, PK ;
Nilsson, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (08) :1074-1079
[2]   Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population [J].
Balada, E ;
Ordi-Ros, J ;
Matas, L ;
Mauri, M ;
Vilardell-Tarrés, SBYM .
MEDICINA CLINICA, 2002, 119 (05) :161-165
[3]   PATIENTS WITH EARLY-ONSET PERIPHERAL VASCULAR-DISEASE HAVE INCREASED LEVELS OF AUTOANTIBODIES AGAINST OXIDIZED LDL [J].
BERGMARK, C ;
WU, R ;
DEFAIRE, U ;
LEFVERT, AK ;
SWEDENBORG, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (04) :441-445
[4]   Positive correlation between in vivo oxidized LDL and LDL immune complexes [J].
Bing, H ;
Wang, JJ ;
Zhang, CN ;
Cai, H .
CLINICAL BIOCHEMISTRY, 2004, 37 (01) :72-75
[5]   ANTI-OXIDIZED LDL ANTIBODIES AND ANTIPHOSPHOLIPID ANTIBODIES IN HEALTHY-SUBJECTS - RELATIONSHIP WITH LIPOPROTEIN-RELATED AND OXIDATION-RELATED ANALYTES [J].
CRAIG, WY ;
POULIN, SE ;
NEVEUX, LM ;
PALOMAKI, GE ;
DOSTALJOHNSON, DA ;
LEDUE, TB ;
RITCHIE, RF .
JOURNAL OF AUTOIMMUNITY, 1995, 8 (05) :713-726
[6]   Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications [J].
Festa, A ;
Kopp, HP ;
Schernthaner, G ;
Menzel, EJ .
DIABETOLOGIA, 1998, 41 (03) :350-356
[7]   Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes [J].
Freigang, S ;
Hörkkö, S ;
Miller, E ;
Witztum, JL ;
Palinski, W .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) :1972-1982
[8]   Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies [J].
Gómez-Zumaquero, JM ;
Tinahones, FJ ;
De Ramón, E ;
Camps, M ;
Garrido, L ;
Soriguer, FJ .
RHEUMATOLOGY, 2004, 43 (04) :510-513
[9]   Low-density lipoprotein and oxidised low-density lipoprotein: Their role in the development of atherosclerosis [J].
Hamilton, CA .
PHARMACOLOGY & THERAPEUTICS, 1997, 74 (01) :55-72
[10]   Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins [J].
Hörkkö, S ;
Bird, DA ;
Miller, E ;
Itabe, H ;
Leitinger, N ;
Subbanagounder, G ;
Berliner, JA ;
Friedman, P ;
Dennis, EA ;
Curtiss, LK ;
Palinski, W ;
Witztum, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (01) :117-128